home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

How Down's Syndrome Protects

 
  June, 4 2009 8:06
your information resource in human molecular genetics
 
     

A genetic explanation for why people with Down's syndrome have a reduced incidence of solid cancers is reported in Nature. The findings identify potential targets for tumour prevention and therapy.

Down's syndrome is a genetic disorder caused by the presence of an extra copy of chromosome 21. It's been known for some time that individuals with Down's syndrome get certain types of cancer less often than those without the condition, although until now little was known about why. Sandra Ryeom and colleagues show that having an extra copy of one of the genes located on chromosome 21, Dscr1, is sufficient to slow cancer growth in a mouse model. Dscr1 seems to work in conjunction with another chromosome 21 gene, Dyrk1a, by interfering with the calcineurin signalling pathway that allows tumours to grow their own blood supply.

The findings offer a mechanism for the reduced frequency of solid cancers in Down's syndrome, and highlight the calcineurin pathway as a potential avenue for therapeutic intervention in cancer.

CONTACT

Sandra Ryeom (Children's Hospital of Boston, MA, USA)
E-mail: sandra.ryeom@childrens.harvard.edu

Abstract available online.

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.